Table 1.
Clinical characteristics of patients with AML.
| Variables | Overall | |
|---|---|---|
| Median | range | |
| Total | 137 | – |
| sex | ||
| Male | 82 | – |
| Female | 55 | – |
| Age (years) | 39.5 | 10-65 |
| WBC (*10 9/L) | 21.07 | 0.16-384.64 |
| HB (g/L) | 97 | 44-163 |
| PLT (*10 9/L) | 24 | 3-431 |
| Blast (%) | 62 | 20.5-90 |
| Karyotype | ||
| normal | 105 | |
| abnormal | 32 | |
| Induction chemotherapy | ||
| Standard scheme (3 + 7) | 99 | – |
| the priming regimen* | 38 | |
| One remission failure | 13 | |
| Relapse patients | 21 | – |
| Transplantation | 52 | |
| Death patients | 20 | – |
*low-dose cytarabine and aclarubicin or homo harringtonine in combination with granulocyte colony-stimulating factor.